Literature DB >> 31634815

Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands.

C Garren Hester1, Michael M Frank2.   

Abstract

Classical pathway activation of the compl ement system is initiated by the binding of the globular head domains of glycoprotein C1q to its corresponding ligand leading to both C1 activation and C3 convertase formation. However, the whereabouts and function of C1q after complement activation have only been marginally investigated. This report presents two mechanisms of action that remove bound C1q from a complement activating IgG immune complex in concentrated serum. The first mechanism details that sequential activation of the classical and alternative pathways releases bound C1q from an immune complex and that the dissociated C1q is subsequently found in complex with complement fragment C3c. The second mechanism is the displacement of C1q from an immune complex by the addition of near physiologic concentrations of purified or serum C1q. This activity can also be demonstrated using serum depleted of C3, normal serum chelated in EDTA, or purified C1. Fresh C1q in C3-depleted serum was found to replace dissociated C1q on the immune complex. C1q dissociated from immune complexes by the mechanism of C1q displacement is able to bind B and T lymphoblastoid cells that express receptors and ligands for both the collagen like region and the globular head domains of C1q. C1q dissociated from immune complexes by the mechanism of C3 activation do not bind these cells. This result suggests that C3 bound to C1q during complement activation and dissociation interferes with the ability of released C1q to access C1q receptors and ligands, particularly receptors for the globular head domains. These underlying mechanisms that regulate the interaction of C1q with its ligands reveal a novel function for complement activation during the immune response.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C1q dissociation; C1q receptors; C1q-C3c complex; C1q/C1 transfer; Complement regulation; Low C1q

Year:  2019        PMID: 31634815     DOI: 10.1016/j.molimm.2019.10.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  [Proteomics of serum exosomes in children in the acute stage of Kawasaki disease: a prospective study].

Authors:  Fan Zhang; Qian-Wen Zhang; Na-Na Wang; Qian Liu; Jie Shen; Miao Hou; Ling Sun; Hai-Tao Lyu; Wen-Hua Yan; Jie Huang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

2.  BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma.

Authors:  Xiyang Zhang; Dongbo Jiang; Shuya Yang; Yuanjie Sun; Yang Liu; Jingqi Shi; Chenchen Hu; Jingyu Pan; Tianyue Liu; Boquan Jin; Kun Yang
Journal:  Front Cell Dev Biol       Date:  2020-12-11

3.  Divergent complement system activation in two clinically distinct murine models of multiple sclerosis.

Authors:  Michael Linzey; Krista DiSano; Nora Welsh; Andrew Pachner; Francesca Gilli
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

4.  Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.

Authors:  Eliott Lafon; Gabriel Diem; Christina Witting; Viktoria Zaderer; Rosa Maria Bellmann-Weiler; Markus Reindl; Angelika Bauer; Andrea Griesmacher; Vilmos Fux; Gregor Hoermann; Carl Miller; August Zabernigg; Ewald Wöll; Doris Wilflingseder; Cornelia Lass-Flörl; Wilfried Posch
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

Review 5.  Live unattenuated vaccines for controlling viral diseases, including COVID-19.

Authors:  Ji-Ming Chen
Journal:  J Med Virol       Date:  2020-09-29       Impact factor: 20.693

6.  Systemic and local evidence for complement involvement in chronic spontaneous urticaria.

Authors:  Mehran Alizadeh Aghdam; Mignon van den Elzen; Harmieke van Os-Medendorp; Marijke R van Dijk; Edward F Knol; André C Knulst; Heike Röckmann; Henny G Otten
Journal:  Clin Transl Allergy       Date:  2021-07-03       Impact factor: 5.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.